Elon Musk’s brain tech firm Neuralink got FDA's OK to begin trials putting brain chips in humans. What is Neuralink doing and ...
Recruitment for the trial is not yet open, but Neuralink said information would be announced soon. The approval comes as its Austin-based competitor, Paradromics, is also moving closer to human trials ...
Elon Musk’s brain-computer interface company Neuralink shared via Twitter that it had received approval from the FDA to begin human clinical trials.
Brain-computer interface company Neuralink announced on 25 May that it has received approval from the US Food and Drug Administration ... to launch our first-in-human clinical study.” ...
NeuraLink, Elon Musk’s venture into medical device industry, yesterday shared updates to its brain implant technology during a “show and tell” event, claiming that the device is about six months away ...
The FDA had pointed out several concerns to Neuralink that needed to be addressed before sanctioning human trials, according ... Thursday’s FDA approval comes as US lawmakers are urging ...
Brain implant company Neuralink announced that it has received approval from US regulators to begin human brain implant ...
After reportedly denying the company's overtures in March, the FDA approved Neuralink's application to begin human trials of its prototype Link brain ... development of the Neuralink BCI since 2018.
Precision Neuroscience announced the completion of the first-in-human procedures for a pilot clinical study of its neural ...
Neuralink is said to have approached one of the largest neurosurgery centers in the U.S ... with the human trials, Neuralink has reportedly engaged in talks with Barrow Neurological Institute ...
In its research since 2018, Neuralink ... US regulations give scientists the ability to determine when and how to use animals for testing and, according to regulatory filings, the company has passed ...
Reuters reported in March that the U.S. Food and Drug Administration rejected Neuralink’s first human ... over the past decade, the agency issued eight citations for conflicts at research ...